Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2020

01-03-2020 | Original Research

Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital

Authors: Anwar Tawfik Amin, Ahmed A. S. Salem, Abeer Ibrahim

Published in: Journal of Gastrointestinal Cancer | Issue 1/2020

Login to get access

Abstract

Background

Adhesions and infiltration into adjacent tissues are present in about 12% of gastrointestinal (GIT) cancers. These adhesions have high potential risk of malignancy. Free resection margin is a predictor of good survival in such patients. This study aims at evaluating the post-operative outcomes after multi-visceral resection of locally advanced gastrointestinal cancers.

Patients and Methods

Ninety patients who underwent extended and multi-visceral resection for GIT cancers invading or adhering to adjacent organs have been included.

Results

For gastric cancer, distal gastrectomy was performed for 12% of the cases and total gastrectomy in 20%. For recto-sigmoid cancer, anterior resection was performed in 18% and abdomino-perineal resection in 7%. Partial colectomy was performed for colonic cancer in 43% of the cases. One organ was excised with GIT tumor in 60 cases (67%). The other 30 cases (33%) required excision of more than one organ. Pathological invasion of adjacent organs was confirmed in 42% of cases. Free margins were obtained in 87% of patients. Morbidity rate was 51%. The most frequent complications were wound infection (17%), anastomotic leak (10%), and chest infection (10%). In this study, 19% required surgical re-intervention. Positive margin and positive lymph nodes (LNs) as well as mucoid adenocarcinoma were associated with a higher recurrence rate.

Conclusion

Achieving free resection margins could be a safe and feasible procedure and may offer good prognosis when followed by adjuvant therapy for patients with locally advanced GIT cancer if patients were precisely selected to have procedure done in a high volume center.
Literature
1.
go back to reference Lopez MJ, Monafo VW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery. 1993;113:365–72.PubMed Lopez MJ, Monafo VW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery. 1993;113:365–72.PubMed
2.
go back to reference Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys. 2001;51(1):176–83.CrossRef Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys. 2001;51(1):176–83.CrossRef
3.
go back to reference Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum. 2001;44(11):1676–81.CrossRef Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum. 2001;44(11):1676–81.CrossRef
4.
go back to reference Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993;177(5):481–7.PubMed Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993;177(5):481–7.PubMed
5.
go back to reference Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chir-urgia (Bucur). 2012;107(4):476–82. Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chir-urgia (Bucur). 2012;107(4):476–82.
8.
go back to reference Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235(2):217–25.CrossRef Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235(2):217–25.CrossRef
9.
go back to reference Beyond TMEC; Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–14.CrossRef Beyond TMEC; Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–14.CrossRef
10.
go back to reference Mañas MJ, Espín E, López-Cano M, Vallribera F, Armengol-Carrasco M. Multivisceralresection for locally advanced rectal cancer: prognostic factors influencing outcome. Scand J Surg. 2015;104(3):154–60.CrossRef Mañas MJ, Espín E, López-Cano M, Vallribera F, Armengol-Carrasco M. Multivisceralresection for locally advanced rectal cancer: prognostic factors influencing outcome. Scand J Surg. 2015;104(3):154–60.CrossRef
11.
go back to reference Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRef Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRef
12.
go back to reference Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109–16.CrossRef Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109–16.CrossRef
13.
go back to reference Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008–15.CrossRef Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008–15.CrossRef
16.
go back to reference Costa SR, Henriques AC, Horta SH, Waisberg J, Speranzini MB. En- bloc pancreatoduodenectomy and right hemicolectomy for treating locally advanced right colon cancer (T4): a series of five patients. Arq Gastroenterol. 2009;46:151–3.CrossRef Costa SR, Henriques AC, Horta SH, Waisberg J, Speranzini MB. En- bloc pancreatoduodenectomy and right hemicolectomy for treating locally advanced right colon cancer (T4): a series of five patients. Arq Gastroenterol. 2009;46:151–3.CrossRef
20.
go back to reference Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.CrossRef Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.CrossRef
22.
go back to reference Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32:198–204.CrossRef Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32:198–204.CrossRef
23.
go back to reference Persiani R, Antonacci V, Biondi A, Rausei S, La Greca A, et al. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13–9.CrossRef Persiani R, Antonacci V, Biondi A, Rausei S, La Greca A, et al. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13–9.CrossRef
24.
go back to reference Fukuda N, Sugiyama Y, Wada J. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection. World J Gastroenterol. 2011;17:1180–4.CrossRef Fukuda N, Sugiyama Y, Wada J. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection. World J Gastroenterol. 2011;17:1180–4.CrossRef
25.
go back to reference Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203:107–11.CrossRef Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203:107–11.CrossRef
26.
go back to reference Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198:25–30.CrossRef Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198:25–30.CrossRef
27.
go back to reference Oñate Ocaña LF, Becker M, Carrillo JF, Aiello Crocifoglio V, Gallardo Rincón D, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98:336–42.CrossRef Oñate Ocaña LF, Becker M, Carrillo JF, Aiello Crocifoglio V, Gallardo Rincón D, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98:336–42.CrossRef
28.
go back to reference Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg. 2011;35:2717–22.CrossRef Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg. 2011;35:2717–22.CrossRef
29.
go back to reference Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer. 2012;15:100–7.CrossRef Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer. 2012;15:100–7.CrossRef
30.
go back to reference Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14–8.CrossRef Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14–8.CrossRef
31.
go back to reference Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48(3):411–23.CrossRef Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48(3):411–23.CrossRef
32.
go back to reference Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612–62.CrossRef Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612–62.CrossRef
33.
go back to reference Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202:223–30.CrossRef Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202:223–30.CrossRef
38.
go back to reference Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100:115–20.CrossRef Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100:115–20.CrossRef
39.
go back to reference D Amato A, Santella S, Cristaldi M, Gentili V, Pronio A, et al. The role of extended total gastrectomy in advanced gastric cancer. Hepato-Gastroenterology. 2004;51:609–12. D Amato A, Santella S, Cristaldi M, Gentili V, Pronio A, et al. The role of extended total gastrectomy in advanced gastric cancer. Hepato-Gastroenterology. 2004;51:609–12.
41.
go back to reference Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430–6.CrossRef Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430–6.CrossRef
Metadata
Title
Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital
Authors
Anwar Tawfik Amin
Ahmed A. S. Salem
Abeer Ibrahim
Publication date
01-03-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0181-5

Other articles of this Issue 1/2020

Journal of Gastrointestinal Cancer 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.